There have been 50 recent insider transactions recorded for Cerevel Therapeutics Holdings, Inc. (CERE), including 20 buys and 29 sells. Total insider buying was valued at RSU Award and total insider selling at $4.2B.
Notable insiders with recent activity include Pfizer Inc, Bain Capital Investors Llc, Patrick Deval L. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CERE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-08-01 |
Pfizer Inc |
Other: Former 10% Owner |
Tender Offer (Sell) |
27,349,211 |
$45.00 |
$1.23B |
- |
| 2024-08-01 |
Bain Capital Investors Llc |
10 Percent Owner |
Return of Shares |
65,679,781 |
$45.00 |
$2.96B |
- |
| 2024-08-01 |
Patrick Deval L |
Director |
Return of Shares |
49,794 |
- |
- |
- |
| 2024-08-01 |
Riedel Norbert G |
Director |
Return of Shares |
95,242 |
- |
- |
- |
| 2024-08-01 |
Coles N Anthony |
Director |
Return of Shares |
4,809,418 |
- |
- |
- |
| 2024-08-01 |
Dekkers Marijn E |
Director |
Return of Shares |
95,242 |
- |
- |
- |
| 2024-08-01 |
Sulzberger Gabrielle |
Director |
Return of Shares |
95,242 |
- |
- |
- |
| 2024-08-01 |
Renaud Ronald C Jr |
President & CEO |
Return of Shares |
320,742 |
- |
- |
- |
| 2024-08-01 |
Giordano Douglas E. |
Director |
Return of Shares |
95,242 |
- |
- |
- |
| 2024-08-01 |
Gordon Christopher R |
10 Percent Owner |
Return of Shares |
80,189 |
- |
- |
- |
| 2024-08-01 |
Mckernan Ruth |
Director |
Return of Shares |
92,986 |
- |
- |
- |
| 2024-08-01 |
Dipietro Kenneth |
Chief Human Resources Officer |
Return of Shares |
63,905 |
- |
- |
- |
| 2024-08-01 |
Koppel Adam |
10 Percent Owner |
Return of Shares |
80,189 |
- |
- |
- |
| 2024-08-01 |
Burgess Paul D. |
See Remarks |
Return of Shares |
81,065 |
- |
- |
- |
| 2024-08-01 |
Akamine Scott |
Chief Legal Officer |
Return of Shares |
59,171 |
- |
- |
- |
| 2024-08-01 |
Altschuller Susan |
Chief Financial Officer |
Return of Shares |
81,065 |
- |
- |
- |
| 2024-08-01 |
Sanchez Ramiro |
Chief Medical Officer |
Return of Shares |
87,573 |
- |
- |
- |
| 2024-08-01 |
Renger John |
Chief Scientific Officer |
Return of Shares |
87,573 |
- |
- |
- |
| 2024-08-01 |
Bodenrader Mark |
See Remarks |
Return of Shares |
24,852 |
- |
- |
- |
| 2024-08-01 |
Tregoning Kathleen |
See Remarks |
Return of Shares |
59,171 |
- |
- |
- |
| 2024-07-01 |
Coles N Anthony |
Director |
Informative Sell |
25,000 |
$41.18 |
$1.03M |
25,928 |
| 2024-06-05 |
Patrick Deval L |
Director |
RSU Award |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Riedel Norbert G |
Director |
RSU Award |
10,461 |
- |
- |
56,553 |
| 2024-06-05 |
Coles N Anthony |
Director |
RSU Award |
10,290 |
- |
- |
25,928 |
| 2024-06-05 |
Dekkers Marijn E |
Director |
RSU Award |
10,461 |
- |
- |
42,283 |
| 2024-06-05 |
Sulzberger Gabrielle |
Director |
RSU Award |
10,461 |
- |
- |
58,876 |
| 2024-06-05 |
Giordano Douglas E. |
Director |
RSU Award |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Gordon Christopher R |
10 Percent Owner |
RSU Award |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Mckernan Ruth |
Director |
RSU Award |
10,461 |
- |
- |
13,743 |
| 2024-06-05 |
Koppel Adam |
10 Percent Owner |
RSU Award |
10,461 |
- |
- |
13,743 |
| 2024-06-03 |
Coles N Anthony |
Director |
Informative Sell |
50,000 |
$40.61 |
$2.03M |
15,638 |
| 2024-05-10 |
Coles N Anthony |
Director |
Informative Sell |
50,000 |
$42.10 |
$2.11M |
15,638 |
| 2024-04-01 |
Coles N Anthony |
Director |
Informative Sell |
50,000 |
$42.33 |
$2.12M |
15,638 |
| 2024-03-04 |
Coles N Anthony |
Director |
Informative Sell |
50,000 |
$41.01 |
$2.05M |
15,638 |
| 2024-02-29 |
Coles N Anthony |
Director |
Informative Sell |
50,000 |
$41.16 |
$2.06M |
15,638 |
| 2024-02-20 |
Perceptive Advisors Llc |
Director |
Gift (Given) |
170,317 |
- |
- |
- |
| 2024-02-07 |
Coles N Anthony |
Director |
Informative Sell |
2,506 |
$41.54 |
$104.11K |
15,638 |
| 2024-02-07 |
Renger John |
Chief Scientific Officer |
Informative Sell |
2,161 |
$41.54 |
$89.78K |
6,370 |
| 2024-02-06 |
Coles N Anthony |
Director |
Option Exercise |
15,440 |
- |
- |
18,144 |
| 2024-02-06 |
Renger John |
Chief Scientific Officer |
Option Exercise |
5,020 |
- |
- |
8,531 |
| 2024-01-19 |
Renaud Ronald C Jr |
President & CEO |
RSU Award |
284,023 |
- |
- |
284,023 |
| 2024-01-19 |
Dipietro Kenneth |
Chief Human Resources Officer |
RSU Award |
63,905 |
- |
- |
63,905 |
| 2024-01-19 |
Burgess Paul D. |
See Remarks |
RSU Award |
81,065 |
- |
- |
81,065 |
| 2024-01-19 |
Akamine Scott |
Chief Legal Officer |
RSU Award |
59,171 |
- |
- |
59,171 |
| 2024-01-19 |
Altschuller Susan |
Chief Financial Officer |
RSU Award |
81,065 |
- |
- |
81,065 |
| 2024-01-19 |
Sanchez Ramiro |
Chief Medical Officer |
RSU Award |
87,573 |
- |
- |
87,573 |
| 2024-01-19 |
Renger John |
Chief Scientific Officer |
RSU Award |
87,573 |
- |
- |
87,573 |
| 2024-01-19 |
Bodenrader Mark |
See Remarks |
RSU Award |
24,852 |
- |
- |
24,852 |
| 2024-01-19 |
Tregoning Kathleen |
See Remarks |
RSU Award |
59,171 |
- |
- |
59,171 |
| 2024-01-02 |
Coles N Anthony |
Director |
Informative Sell |
50,000 |
$42.24 |
$2.11M |
2,704 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
